STOCK TITAN

[8-K] Beneficient Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Beneficient (NASDAQ:BENF) filed an 8-K announcing the closing of a significant equity transaction on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for acquiring a limited partner interest in an investment fund valued at $1.91 million.

The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares will automatically convert on specific trigger events, including the fifth anniversary of issuance.

Beneficient (NASDAQ:BENF) ha presentato un modulo 8-K annunciando la chiusura di una significativa operazione azionaria il 17 giugno 2025. La società ha emesso 191.037 azioni di Azioni Preferenziali Convertibili Resettable Serie B-8 in cambio dell'acquisizione di una quota di socio accomandatario in un fondo di investimento valutato 1,91 milioni di dollari.

Le Azioni Preferenziali Serie B-8 sono convertibili in Azioni Ordinarie di Classe A a un prezzo di conversione iniziale di 0,3397 dollari per azione, soggetto a reset mensili e a un prezzo minimo di 0,2548 dollari. Al massimo, potranno essere emesse 7.497.528 azioni ordinarie di Classe A in seguito alla conversione. Le azioni preferenziali si convertiranno automaticamente al verificarsi di eventi specifici, incluso il quinto anniversario dell’emissione.

Beneficient (NASDAQ:BENF) presentó un formulario 8-K anunciando el cierre de una importante transacción de capital el 17 de junio de 2025. La compañía emitió 191,037 acciones de Acciones Preferentes Convertibles Resetables Serie B-8 a cambio de adquirir una participación limitada en un fondo de inversión valorado en 1,91 millones de dólares.

Las Acciones Preferentes Serie B-8 son convertibles en Acciones Ordinarias Clase A a un precio inicial de conversión de 0,3397 dólares por acción, sujeto a reajustes mensuales y un precio mínimo de 0,2548 dólares. Se podrán emitir hasta 7.497.528 acciones ordinarias Clase A tras la conversión. Las acciones preferentes se convertirán automáticamente en eventos desencadenantes específicos, incluido el quinto aniversario de la emisión.

Beneficient (NASDAQ:BENF)는 2025년 6월 17일 주요 주식 거래 마감을 알리는 8-K 보고서를 제출했습니다. 회사는 191만 달러 상당의 투자 펀드 유한 파트너 지분을 취득하는 대가로 B-8 시리즈 리셋 가능 전환 우선주 191,037주를 발행했습니다.

B-8 시리즈 우선주는 초기 전환 가격이 주당 0.3397달러이며, 월별 리셋과 최저 가격 0.2548달러가 적용됩니다. 최대 7,497,528주의 A 클래스 보통주로 전환될 수 있습니다. 우선주는 발행 5주년 등 특정 조건 발생 시 자동으로 전환됩니다.

Beneficient (NASDAQ:BENF) a déposé un formulaire 8-K annonçant la clôture d'une transaction importante en actions le 17 juin 2025. La société a émis 191 037 actions privilégiées convertibles réinitialisables de la série B-8 en échange de l'acquisition d'une participation de commandité dans un fonds d'investissement évalué à 1,91 million de dollars.

Les actions privilégiées de la série B-8 sont convertibles en actions ordinaires de classe A à un prix de conversion initial de 0,3397 $ par action, soumis à des réinitialisations mensuelles et à un prix plancher de 0,2548 $. Un maximum de 7 497 528 actions ordinaires de classe A peut être émis lors de la conversion. Les actions privilégiées seront automatiquement converties lors d'événements déclencheurs spécifiques, y compris le cinquième anniversaire de leur émission.

Beneficient (NASDAQ:BENF) reichte ein 8-K ein, in dem der Abschluss einer bedeutenden Eigenkapitaltransaktion am 17. Juni 2025 bekannt gegeben wurde. Das Unternehmen gab 191.037 Aktien der Serie B-8 Resettable Convertible Preferred Stock im Austausch für den Erwerb einer Kommanditbeteiligung an einem Investmentfonds im Wert von 1,91 Millionen US-Dollar aus.

Die Serie B-8 Preferred Stock ist in Class A Stammaktien zu einem anfänglichen Umwandlungspreis von 0,3397 USD pro Aktie wandelbar, vorbehaltlich monatlicher Anpassungen und einem Mindestpreis von 0,2548 USD. Maximal 7.497.528 Aktien der Class A Stammaktien können bei der Umwandlung ausgegeben werden. Die Vorzugsaktien werden bei bestimmten Auslöseereignissen, einschließlich des fünften Jahrestags der Ausgabe, automatisch umgewandelt.

Positive
  • Creative financing structure acquiring $1.91M in investment fund assets
  • Monthly reset feature provides flexibility in conversion terms
  • Built-in investor protections with floor price mechanisms
Negative
  • Significant dilution potential with up to 7.49M new common shares
  • Complex preferred stock structure adds to capital complexity
  • Junior ranking to multiple other preferred stock series

Insights

Complex convertible preferred stock issuance with significant dilution potential and regulatory compliance considerations

The transaction structure reveals sophisticated financial engineering with multiple investor protections. The monthly reset mechanism of the conversion price, subject to a 75% floor, provides downside protection while maintaining upside potential. The inclusion of both beneficial ownership limitations (4.99%) and exchange cap provisions demonstrates careful regulatory compliance with Nasdaq rules. The mandatory conversion features tied to SEC filing compliance and Rule 144 eligibility indicate a well-structured path to eventual common stock conversion.

Strategic capital raise through alternative asset acquisition structure with significant potential dilution risk

This transaction represents a creative financing approach, effectively valuing the acquired fund interest at 10x the preferred share par value. The conversion mechanics, particularly the monthly reset feature, create potential dilution risk as the conversion price can adjust downward to 75% of initial price. With maximum potential issuance of 7.49M common shares against current value of $1.91M, the effective minimum conversion price implies significant dilution potential. The pari passu dividend rights with common stock but junior ranking to other preferred series suggests a balanced risk-reward structure.

Beneficient (NASDAQ:BENF) ha presentato un modulo 8-K annunciando la chiusura di una significativa operazione azionaria il 17 giugno 2025. La società ha emesso 191.037 azioni di Azioni Preferenziali Convertibili Resettable Serie B-8 in cambio dell'acquisizione di una quota di socio accomandatario in un fondo di investimento valutato 1,91 milioni di dollari.

Le Azioni Preferenziali Serie B-8 sono convertibili in Azioni Ordinarie di Classe A a un prezzo di conversione iniziale di 0,3397 dollari per azione, soggetto a reset mensili e a un prezzo minimo di 0,2548 dollari. Al massimo, potranno essere emesse 7.497.528 azioni ordinarie di Classe A in seguito alla conversione. Le azioni preferenziali si convertiranno automaticamente al verificarsi di eventi specifici, incluso il quinto anniversario dell’emissione.

Beneficient (NASDAQ:BENF) presentó un formulario 8-K anunciando el cierre de una importante transacción de capital el 17 de junio de 2025. La compañía emitió 191,037 acciones de Acciones Preferentes Convertibles Resetables Serie B-8 a cambio de adquirir una participación limitada en un fondo de inversión valorado en 1,91 millones de dólares.

Las Acciones Preferentes Serie B-8 son convertibles en Acciones Ordinarias Clase A a un precio inicial de conversión de 0,3397 dólares por acción, sujeto a reajustes mensuales y un precio mínimo de 0,2548 dólares. Se podrán emitir hasta 7.497.528 acciones ordinarias Clase A tras la conversión. Las acciones preferentes se convertirán automáticamente en eventos desencadenantes específicos, incluido el quinto aniversario de la emisión.

Beneficient (NASDAQ:BENF)는 2025년 6월 17일 주요 주식 거래 마감을 알리는 8-K 보고서를 제출했습니다. 회사는 191만 달러 상당의 투자 펀드 유한 파트너 지분을 취득하는 대가로 B-8 시리즈 리셋 가능 전환 우선주 191,037주를 발행했습니다.

B-8 시리즈 우선주는 초기 전환 가격이 주당 0.3397달러이며, 월별 리셋과 최저 가격 0.2548달러가 적용됩니다. 최대 7,497,528주의 A 클래스 보통주로 전환될 수 있습니다. 우선주는 발행 5주년 등 특정 조건 발생 시 자동으로 전환됩니다.

Beneficient (NASDAQ:BENF) a déposé un formulaire 8-K annonçant la clôture d'une transaction importante en actions le 17 juin 2025. La société a émis 191 037 actions privilégiées convertibles réinitialisables de la série B-8 en échange de l'acquisition d'une participation de commandité dans un fonds d'investissement évalué à 1,91 million de dollars.

Les actions privilégiées de la série B-8 sont convertibles en actions ordinaires de classe A à un prix de conversion initial de 0,3397 $ par action, soumis à des réinitialisations mensuelles et à un prix plancher de 0,2548 $. Un maximum de 7 497 528 actions ordinaires de classe A peut être émis lors de la conversion. Les actions privilégiées seront automatiquement converties lors d'événements déclencheurs spécifiques, y compris le cinquième anniversaire de leur émission.

Beneficient (NASDAQ:BENF) reichte ein 8-K ein, in dem der Abschluss einer bedeutenden Eigenkapitaltransaktion am 17. Juni 2025 bekannt gegeben wurde. Das Unternehmen gab 191.037 Aktien der Serie B-8 Resettable Convertible Preferred Stock im Austausch für den Erwerb einer Kommanditbeteiligung an einem Investmentfonds im Wert von 1,91 Millionen US-Dollar aus.

Die Serie B-8 Preferred Stock ist in Class A Stammaktien zu einem anfänglichen Umwandlungspreis von 0,3397 USD pro Aktie wandelbar, vorbehaltlich monatlicher Anpassungen und einem Mindestpreis von 0,2548 USD. Maximal 7.497.528 Aktien der Class A Stammaktien können bei der Umwandlung ausgegeben werden. Die Vorzugsaktien werden bei bestimmten Auslöseereignissen, einschließlich des fünften Jahrestags der Ausgabe, automatisch umgewandelt.

false --03-31 0001775734 0001775734 2025-06-17 2025-06-17 0001775734 us-gaap:CommonClassAMember 2025-06-17 2025-06-17 0001775734 us-gaap:WarrantMember 2025-06-17 2025-06-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 17, 2025

 

 

 

Beneficient

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada   001-41715   72-1573705

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

325 North St. Paul Street, Suite 4850

Dallas, Texas 75201

(Address of Principal Executive Offices, and Zip Code)

 

(214) 445-4700

Registrant’s Telephone Number, Including Area Code

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Shares of Class A common stock, par value $0.001 per share   BENF   Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock, par value $0.001 per share, and one share of Series A convertible preferred stock, par value $0.001 per share   BENFW   Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Series B-8 Primary Capital Transaction

 

On June 17, 2025, Beneficient, a Nevada corporation (the “Company”), through one of its subsidiaries, closed a primary capital transaction for which an agreement was entered on May 22, 2025 with a customer with respect to a limited partner interest in an investment fund with a net asset value of $1,910,370 (the “Transaction”). Pursuant to the Transaction, the Company’s customized trust vehicles acquired a limited partner interest, and in exchange for such, the customer received 191,037 shares of the Company’s Series B-8 Resettable Convertible Preferred Stock, par value $0.001 per share (the “Series B-8 Preferred Stock”), with such Series B-8 Preferred Stock being convertible into shares of the Company’s Class A Common Stock, par value $0.001 per share (the “Class A Common Stock”).

 

The issuance of the Series B-8 Preferred Stock pursuant to the Transaction was not registered under the Securities Act of 1933, as amended (the “Securities Act”), and was issued in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder.

 

The Series B-8 Preferred Stock is convertible into Class A Common Stock initially at a conversion price of $0.3397 per share (the “B-8 Conversion Price”). The B-8 Conversion Price is subject to reset from time to time and a floor price of $0.2548 per share. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion of the Series B-8 Preferred Stock. The information in Item 5.03 concerning the material terms of the Series B-8 Preferred Stock is incorporated by reference herein.

 

Item 3.03 Material Modifications to Rights of Security Holders.

 

The disclosure required by this Item 3.03 is included in Item 5.03 of this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Series B-8 Preferred Stock

 

On June 17, 2025, the Company filed a certificate of designation (the “B-8 Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B-8 Preferred Stock. The material terms of the Series B-8 Preferred Stock are described below. The total number of authorized shares of the Series B-8 Preferred Stock is 191,037 shares.

 

Optional Conversion

 

Each share of Series B-8 Preferred Stock is convertible, at the option of the holder thereof upon two business days’ written notice to the Company, into a number of shares of Class A Common Stock that is equal to $10.00 divided by the B-8 Conversion Price in effect as of the date of such notice (the “B-8 Conversion Rate”). The B-8 Conversion Price shall be subject to reset on each date (each such date, a “B-8 Reset Date”) that is the last day of each month following the date of issuance of the Series B-8 Preferred Stock (the “B-8 Original Issue Date”). On each B-8 Reset Date, the B-8 Conversion Price shall be increased or decreased to the five day trailing volume weighted average price of the Class A Common Stock on the Nasdaq Capital Market or such other national securities exchange on which the Class A Common Stock is listed for trading as of the applicable B-8 Reset Date as reported by Bloomberg Financial Markets or an equivalent reporting service as determined by the Company (the “Prevailing Market Price”), provided that in no event shall the reset B-8 Conversion Price be (a) less than 75% of the initial B-8 Conversion Price or (b) higher than the initial B-8 Conversion Price, in each case subject to adjustments for stock dividends, splits or combinations, reorganizations, recapitalizations or similar transactions. As further described in the B-8 Certificate of Designation, the Company will not issue any shares of Class A Common Stock upon conversion of any Series B-8 Preferred Stock if the issuance of such shares of Class A Common Stock would exceed the Exchange Cap (as defined below), except that such limitation shall not apply in the event that the Company obtains the approval of its stockholders as required by the applicable rules and regulations of The Nasdaq Stock Market, LLC (“Nasdaq”) for issuances of shares of Class A Common Stock in excess of the Exchange Cap.

 

 

 

 

Mandatory Conversion

 

Each outstanding share of Series B-8 Preferred Stock will automatically convert into a number of shares of Class A Common Stock (the “B-8 Mandatory Conversion”) as is determined by the B-8 Conversion Rate then in effect on the date (the “B-8 Mandatory Conversion Date”) that is the earliest to occur of: (a) the last day of the month in which the fifth anniversary of the B-8 Original Issue Date occurs, if either the Company has filed all annual reports on Form 10-K and quarterly reports on Form 10-Q that are then required to have been filed in the preceding twelve months with the United States Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or a resale registration statement with respect to the shares of Class A Common Stock underlying the Series B-8 Preferred Stock (the “B-8 Resale Registration Statement”) has become effective and is in full force and effect at the time of such B-8 Mandatory Conversion and (b) if the conditions of clause (a) are not met on the date that is the last day of the month in which the fifth anniversary of the B-8 Original Issue Date occurs, the first date thereafter on which any shares of Series B-8 Preferred Stock may be resold pursuant to Rule 144 under the Securities Act, or the B-8 Resale Registration Statement has become effective. Notwithstanding the foregoing, the Series B-8 Preferred Stock shall not convert into Class A Common Stock to the extent such conversion would cause a holder to exceed (i) 4.99% (the “B-8 Beneficial Ownership Limitation”) of the number of shares of the Class A Common Stock outstanding immediately after giving effect to the issuance of shares of Class A Common Stock issuable upon conversion of Series B-8 Preferred Stock held by the applicable holder or (ii) the aggregate number of shares of Class A Common Stock that the Company may issue upon conversion of the Series B-8 Preferred Stock without breaching the Company’s obligations under the rules and regulations of Nasdaq (the number of shares which may be issued without violating such rules and regulations, the “Exchange Cap”). To the extent a conversion would cause a holder to exceed the B-8 Beneficial Ownership Limitation or Exchange Cap, as applicable, the conversion of the portion of such conversion that would exceed the B-8 Beneficial Ownership Limitation or Exchange Cap, as applicable, shall be delayed until the first day the conversion of such portion would not cause the holder to exceed the B-8 Beneficial Ownership Limitation or, with respect to the Exchange Cap, when stockholder approval as required by the applicable rules and regulations of Nasdaq has been obtained. Further, to the extent any such share of Series B-8 Preferred Stock has not otherwise automatically converted into shares of Class A Common Stock, the B-8 Conversion Price for such shares shall be subject to additional resets on the terms described in the B-8 Certificate of Designation on the last date of each month.

 

Ranking

 

Series B-8 Preferred Stock will, with respect to dividend rights and rights upon liquidation, dissolution or winding up of the Company, rank: (a) pari passu to the Class A Common Stock; (b) junior with respect to the Company’s Series A Convertible Preferred Stock, par value $0.001 per share, Series B-1 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-2 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-3 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-4 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-5 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-6 Resettable Convertible Preferred Stock, par value $0.001 per share and Series B-7 Resettable Convertible Preferred Stock, par value $0.001 per share; (c) senior, pari passu or junior with respect to any other series of preferred stock, as set forth in the Certificate of Designation with respect to such preferred stock; and (d) junior to all existing and future indebtedness of the Company.

 

Liquidation Preference

 

In the event of any liquidation or dissolution of the Company, the holders of Series B-8 Preferred Stock shall be entitled receive, pro rata with the holders of the Company’s Class A Common Stock, and any other shares of preferred stock of the Company identified as “Designated Preferred Stock,” a per share amount equal to such amount per share as would have been payable had all shares of Series B-8 Preferred Stock been converted to Class A Common Stock pursuant to Section 8 of the B-8 Certificate of Designation (without giving effect to any ownership limitations therein) immediately prior to such liquidation or dissolution of the Company (the “Liquidation Preference”). The Series B-8 Preferred Stock shall be a series of Designated Preferred Stock.

 

 

 

 

Dividends

 

Dividends will be paid on the Series B-8 Preferred Stock on an as-converted basis when, as, and if paid on the Class A Common Stock.

 

Voting Rights

 

Except as required by law, the holders of Series B-8 Preferred Stock shall not be entitled to vote at any meeting of the stockholders for election of members of the Board of Directors of the Company or for any other purpose or otherwise to participate in any action taken by the Company or the stockholders thereof, or to receive notice of any meeting of stockholders.

 

The foregoing summary of the B-8 Certificate of Designation does not purport to be complete and is subject to, and qualified in its entirety by, such document, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure.

 

On June 24, 2025, the Company issued a press release announcing the closing of the Transaction.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

The information in this Item 7.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as expressly set forth in such filing.

 

Item 9.01 Exhibits and Financial Statements.

 

(d) Exhibits.

 

Exhibit

No.

  Description of Exhibit
   
3.1   Certificate of Designation of Series B-8 Resettable Convertible Preferred Stock.
   
99.1   Press Release issued by Beneficient on June 24, 2025.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL).

 

Cautionary Note Regarding Forward-Looking Statements

 

Except for the historical information contained herein, the matters set forth in this Current Report on Form 8-K are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this Current Report include, without limitation, statements related to the Transaction and the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock. These and other forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could significantly affect expected results. Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among other things, the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.

 

 

 

 

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

 

Important Information and Where You Can Find It

 

This Current Report on Form 8-K may be deemed to be solicitation material in respect of a vote of stockholders to approve the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock. In connection with the requisite stockholder approval, the Company will file with the SEC a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of the Company, seeking such approvals related to the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock.

 

INVESTORS AND SECURITY HOLDERS OF THE COMPANY AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION DESCRIBED HEREIN, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE TRANSACTION. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about the Company, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by the Company can also be obtained, without charge, by directing a request to Investor Relations, Beneficient at 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201 or email investors@beneficient.com.

 

Participants in the Solicitation of Proxies in Connection with Transaction

 

The Company and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding the Company’s directors and executive officers is available in its Annual Report on Form 10-K, which was filed with the SEC on July 9, 2024, and certain current reports on Form 8-K filed by the Company. Other information regarding the participants in the solicitation of proxies with respect to the transaction described herein and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.

 

Not an Offer of Securities

 

The information in this Current Report on Form 8-K is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the transaction described herein have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BENEFICIENT
     
  By:

/s/ Gregory W. Ezell

  Name:  Gregory W. Ezell
  Title: Chief Financial Officer
     
  Dated: June 25, 2025

 

 

 

FAQ

What assets did BENF acquire in this transaction?

BENF acquired a limited partner interest in an investment fund with a net asset value of $1,910,370 through its subsidiary's customized trust vehicles.

How many Series B-8 Preferred shares were issued by BENF?

BENF issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in the transaction.

What is the conversion price for BENF's Series B-8 Preferred Stock?

The initial conversion price is $0.3397 per share, subject to monthly resets, with a floor price of $0.2548 per share.

When does BENF's Series B-8 Preferred Stock mandatorily convert?

Mandatory conversion occurs at the earlier of the fifth anniversary of issuance (subject to SEC filing compliance) or when the shares become eligible for resale under Rule 144.
Beneficient-A

NASDAQ:BENF

BENF Rankings

BENF Latest News

BENF Latest SEC Filings

BENF Stock Data

2.44M
7.14M
13.76%
12.8%
1.26%
Asset Management
Finance Services
Link
United States
DALLAS